← SynDRA
OLODANRIGAN
SynDRA canonical compound SYN0001929 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | AGTR2 | MTUS1 |
|---|
| Mechanism of action | angiotensin antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- AGTR2 ANTAGONIST
- Angiotensin II type 2 (AT-2) receptor antagonist
- angiotensin antagonist
Cross-references
Synonyms
- EMA401
- EMA-401
- PD-126055
- Neuropathic pain targeting small molecules (postherpetic neuralgia), Spinifex
- P0FN522VTO
- olodanriganum
- RefChem:1050288
- PD-126055 free acid
- MFCD28502251
- Olodanrigan [WHO-DD]
- Olodanrigan (EMA401)
- Olodanrigan(EMA401)
- EMA401; Olodanrigan
- OLODANRIGAN [INN]
- UNII-P0FN522VTO
- [S]-enantiomer of EMA400
- Olodanrigan; PD-126055
- SCHEMBL421411
- GTPL8374
- orb1302865
- SCHEMBL29394365
- EX-A2623
- [S]-enantiomer of PD-126,055
- BDBM50049182
- AKOS026676520
- CS-5781
- AC-35554
- AS-53290
- DA-63168
- HY-13106
- T4431
- P16290
- F870300
- Olodanrigan,EMA 401,EMA-401,EMA401,1418274-28-8
- Olodanrigan sodium
- PD-126055 sodium
- EMA-401 sodium
- PD-126055sodiumsalt
- DA-63169
Look up OLODANRIGAN in the interactive SynDRA portal →